Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

SHARDA CROPCHEM 2023-24 Annual Report Analysis
Thu, 11 Jul

SHARDA CROPCHEM has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

SHARDA CROPCHEM Income Statement Analysis

  • Operating income during the year fell 21.8% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 53.9% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 9.6% in FY24 as against 16.3% in FY23.
  • Depreciation charges increased by 7.7% and finance costs increased by 19.9% YoY, respectively.
  • Other income grew by 48.4% YoY.
  • Net profit for the year declined by 90.7% YoY.
  • Net profit margins during the year declined from 8.5% in FY23 to 1.0% in FY24.

SHARDA CROPCHEM Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 40,452 31,630 -21.8%
Other income Rs m 403 598 48.4%
Total Revenues Rs m 40,854 32,228 -21.1%
Gross profit Rs m 6,588 3,034 -53.9%
Depreciation Rs m 2,481 2,671 7.7%
Interest Rs m 202 242 19.9%
Profit before tax Rs m 4,307 719 -83.3%
Tax Rs m 888 400 -55.0%
Profit after tax Rs m 3,420 319 -90.7%
Gross profit margin % 16.3 9.6
Effective tax rate % 20.6 55.6
Net profit margin % 8.5 1.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Key Information for Long-term Investors

SHARDA CROPCHEM Balance Sheet Analysis

  • The company's current liabilities during FY24 down at Rs 16 billion as compared to Rs 20 billion in FY23, thereby witnessing an decrease of -20.5%.
  • Current assets fell 10% and stood at Rs 30 billion, while fixed assets rose 4% and stood at Rs 16 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 46 billion as against Rs 49 billion during FY23, thereby witnessing a fall of 6%.

SHARDA CROPCHEM Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 22,320 22,371 0.2
 
Current Liabilities Rs m 20,265 16,102 -20.5
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 48,757 45,922 -5.8
 
Current assets Rs m 33,141 29,676 -10.5
Fixed Assets Rs m 15,616 16,246 4.0
Total Assets Rs m 48,757 45,922 -5.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



SHARDA CROPCHEM Cash Flow Statement Analysis

  • SHARDA CROPCHEM's cash flow from operating activities (CFO) during FY24 stood at Rs 3 billion, an improvement of 4.0% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -4 billion, an improvement of 171.1% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -369 million, an improvement of 62% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -890 million from the Rs 1 billion net cash flows seen during FY23.

SHARDA CROPCHEM Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 3,283 3,413 4.0%
Cash Flow from Investing Activities Rs m -1,452 -3,935 -
Cash Flow from Financing Activities Rs m -971 -369 -
Net Cash Flow Rs m 1,197 -890 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for SHARDA CROPCHEM

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 3.5, an decline from the EPS of Rs 37.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 502.3, stands at 142.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.0 times, while the price to sales ratio stands at 1.4 times.
  • The company's price to cash flow (P/CF) ratio stood at 13.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 448.4 350.6
TTM Earnings per share Rs 37.9 3.5
Diluted earnings per share Rs 37.9 3.5
Price to Cash Flow x 7.5 13.5
TTM P/E ratio x 12.9 142.0
Price / Book Value ratio x 2.3 1.8
Market Cap Rs m 51,268 40,509
Dividends per share (Unadj.) Rs 6.0 3.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for SHARDA CROPCHEM

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.8x during FY24, from 1.6x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 4.0x during FY24, from 22.4x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 1.4% during FY24, from 15.3% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 4.3% during FY24, from 20.2% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 1.2% during FY24, from 7.4% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 1.6 1.8
Debtors’ Days Days 1,654 1,729
Interest coverage x 22.4 4.0
Debt to equity ratio x 0.0 0.0
Return on assets % 7.4 1.2
Return on equity % 15.3 1.4
Return on capital employed % 20.2 4.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how SHARDA CROPCHEM has performed over the last 5 years, please visit here.

SHARDA CROPCHEM Share Price Performance

Over the last one year, SHARDA CROPCHEM share price has moved down from Rs 544.2 to Rs 502.3, registering a loss of Rs 41.9 or around 7.7%.

Overall, the S&P BSE SENSEX is up 22.0% over the year.

(To know more, check out historical annual results for SHARDA CROPCHEM and quarterly results for SHARDA CROPCHEM)

Annual Report FAQs

What is the current share price of SHARDA CROPCHEM?

SHARDA CROPCHEM currently trades at Rs 805.7 per share. You can check out the latest share price performance of SHARDA CROPCHEM here...

What was the revenue of SHARDA CROPCHEM in FY24? How does it compare to earlier years?

The revenues of SHARDA CROPCHEM stood at Rs 32,228 m in FY24, which was down -21.1% compared to Rs 40,854 m reported in FY23.

SHARDA CROPCHEM's revenue has grown from Rs 20,461 m in FY20 to Rs 32,228 m in FY24.

Over the past 5 years, the revenue of SHARDA CROPCHEM has grown at a CAGR of 12.0%.

What was the net profit of SHARDA CROPCHEM in FY24? How does it compare to earlier years?

The net profit of SHARDA CROPCHEM stood at Rs 319 m in FY24, which was down -90.7% compared to Rs 3,420 m reported in FY23.

This compares to a net profit of Rs 3,493 m in FY22 and a net profit of Rs 2,292 m in FY21.

Over the past 5 years, SHARDA CROPCHEM net profit has grown at a CAGR of -33.7%.

What does the cash flow statement of SHARDA CROPCHEM reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of SHARDA CROPCHEM reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 3,413 m as compared to Rs 3,283 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -3,935 m as compared to Rs -1,452 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs -369 m as compared to Rs -971 m in FY23.

Here's the cash flow statement of SHARDA CROPCHEM for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations1,4632,4642,6713,2833,413
From Investments-678-2,816-2,079-1,452-3,935
From Financial Activity-597434-910-971-369
Net Cashflow27178-2891,197-890

What does the Key Ratio analysis of SHARDA CROPCHEM reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of SHARDA CROPCHEM reveals:

  • Operating profit margins witnessed a fall and stood at 9.6% in FY24 as against 16.3% in FY23.
  • Net profit margins declined from 8.5% in FY23 to 1.0% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of SHARDA CROPCHEM for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)14.718.019.416.39.6
Net Profit Margin (%)8.29.69.88.51.0
Debt to Equity Ratio (x)0.00.00.00.00.0

Equitymaster requests your view! Post a comment on "SHARDA CROPCHEM 2023-24 Annual Report Analysis". Click here!